Subtype specific internalization of P2Y 1 and P2Y 2 receptors induced by novel adenosine 5′-O-(1-boranotriphosphate) derivatives

British Journal of Pharmacology

Volumn 142, Issue 5, 2004, Pages 869-878

  Tulapurkar, M E ^a   Laubinger, W ^a   Nahum, V ^b   Fischer, B ^b   Reiser, G ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Adenosine 5 O (1 boranotriphosphate) derivatives; Green fluorescent protein; Human embryonic kidney (HEK 293) cells; Purinergic receptor; Receptor endocytosis

Indexed keywords

ADENOSINE DERIVATIVE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ARACHIDONIC ACID; BORANE DERIVATIVE; PHOSPHORUS DERIVATIVE; PROTEIN DERIVATIVE; PURINE P2Y1 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; CALCIUM TRANSPORT; CELL LINE; CONTROLLED STUDY; DERIVATIZATION; DRUG POTENCY; DRUG SCREENING; ENDOCYTOSIS; EXPERIMENTAL TEST; EXPERIMENTATION; FLUORESCENCE ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN STABILITY; STEREOISOMERISM; SUBSTITUTION REACTION;

ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; CALCIUM; CELL LINE; DNA, COMPLEMENTARY; ENDOCYTOSIS; GREEN FLUORESCENT PROTEINS; HUMANS; ISOTOPE LABELING; MICROSCOPY, CONFOCAL; MOLECULAR CONFORMATION; RECEPTORS, PURINERGIC P2; RECOMBINANT PROTEINS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 3242884617     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705859     Document Type: Article

References (56)

1. ABBRACCHIO, M.P., BOEYNAEMS, J.M., BARNARD, E.A., BOYER, J.L., KENNEDY, C., MIRAS-PORTUGAL, M.T., KING, B.F., GACHET, C., JACOBSON, K.A., WEISMAN, G.A. & BURNSTOCK, G. (2003). Characterization of the UDP-glucose receptor (re-named here the P2YI4 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci., 24, 52-55.
2. BARLIC, J., KHANDAKER, M.H., MAHON, E., ANDREWS, J., DEVRIES, M.E., MITCHELL, G.B., RAHIMPOUR, R., TAN, C.M., FERGUSON, S.S. & KELVIN, D.J. (1999). Beta-arrestins regulate interleukin-8-induced CXCR1 internalization. J. Biol. Chem., 274, 16287-16294.
3. BARNARD, E.A., SIMON, J. & WEBB, T.E. (1997). Nucleotide receptors in the nervous system. An abundant component using diverse transduction mechanisms. Mol. Neurobiol., 15, 103-129.
4. BAURAND, A., ECKLY, A., BARI, N., LEON, C., HECHLER, B., CAZENAVE, J.P. & GACHET, C. (2000). Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb. Haemost., 84, 484-491.
5. BERENBAUM, F., HUMBERT, L., BEREZIAT, G. & THIRION, S. (2003). Concomitant recruitment of ERK1/2 and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes. J. Biol. Chem., 278, 13680-13687.
6. BOARDER, M.R. & HOURANI, S.M. (1998). The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol. Sci., 19, 99-107.
7. BÖHM, S.K., KHITIN, L.M., GRADY, E.F., APONTE, G., PAYAN, D.G. & BUNNETT, N.W. (1996). Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J. Biol. Chem., 271, 22003-22016.
8. 1 receptor antagonist. Br. J. Pharmacol., 135, 2004-2010.
9. 6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br. J. Pharmacol., 124, 1-3.
10. BRAMBILLA, R. & ABBRACCHIO, M.P. (2001). Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann. N. Y. Acad. Sci., 939, 54-62.
11. CHAMBERS, J.K., MACDONALD, L.E., SARAU, H.M., AMES, R.S., FREEMAN, K., FOLEY, J.J., ZHU, Y., MCLAUGHLIN, M.M., MURDOCK, P., MCMILLAN, L., TRILL, J., SWIFT, A., AIYAR, N., TAYLOR, P., VAWTER, L., NAHEED, S., SZEKERES, P., HERVIEU, G., SCOTT, C., WATSON, J.M., MURPHY, A.J., DUZIC, E., KLEIN, C., BERGSMA, D.J., WILSON, S. & LIVI, G.P. (2000). A G protein-coupled receptor for UDP-glucose. J. Biol. Chem., 275, 10767-10771.
12. CHANG, K., HANAOKA, K., KUMADA, M. & TAKUWA, Y. (1995). Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J. Biol. Chem., 270, 26152-26158.
13. 2 receptor-activated transepithelial anion secretion. Am. J. Physiol., 276, C777-C787.
14. COMMUNI, D., GOVAERTS, C., PARMENTIER, M. & BOEYNAEMS, J.M. (1997). Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J. Biol. Chem., 272, 31969-31973.
15. COMMUNI, D., PIROTTON, S., PARMENTIER, M. & BOEYNAEMS, J.M. (1995). Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem., 270, 30849-30852.
16. COMMUNI, D., ROBAYE, B. & BOEYNAEMS, J.M. (1999). Pharmacological characterization of the human P2Y11 receptor. Br. J. Pharmacol., 128, 1199-1206.
17. DUBYAK, G.R. (2003). Knock-out mice reveal tissue-specific roles of P2Y receptor subtypes in different epithelia. Mol. Pharmacol., 63, 773-776.
18. FISCHER, B., BOYER, J.L., HOYLE, C.H., ZIGANSHIN, A.U., BRIZZOLARA, A.L., KNIGHT, G.E., ZIMMET, J., BURNSTOCK, G., HARDEN, T.K. & JACOBSON, K.A. (1993). Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5′-triphosphate. J. Med. Chem., 36, 3937-3946.
19. FREEDMAN, N.J. & LEFKOWITZ, R.J. (1996). Desensitization of G protein-coupled receptors. Recent Prog. Horm. Res., 51, 319-351.
20. GUILE, S.D., INCE, F., INGALL, A.H., KINDON, N.D., MEGHANI, P. & MORTIMORE, M.P. (2001). The medicinal chemistry of the P2 receptor family. Prog. Med. Chem., 38, 115-187.
21. 2 receptors in rat mesangial cells. Biochem. Biophys. Res. Commun., 270, 594-599.
22. 1-receptor. 1. A synthetic, biochemical, and NMR approach. J. Med. Chem., 42, 5325-5337.
23. 2+-sensing receptor is a promiscuous divalent cation sensor that responds to lead. Am. J. Physiol. Renal Physiol., 279, F1083-F1091.
24. HOMOLYA, L., STEINBERG, T.H. & BOUCHER, R.C. (2000). Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J. Cell Biol., 150, 1349-1360.
25. HUANG, P., LAZAROWSKI, E.R., TARRAN, R., MILGRAM, S.L., BOUCHER, R.C. & STUTTS, M.J. (2001). Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells. Proc. Natl. Acad. Sci. U.S.A., 98, 14120-14125.
26. 2 purinoceptor in renal mesangial cells. Br. J. Pharmacol., 136, 520-529.
27. INSEL, P.A., OSTROM, R.S., ZAMBON, A.C., HUGHES, R.J., BALBOA, M.A., SHEHNAZ, D., GREGORIAN, C., TORRES, B., FIRESTEIN, B.L., XING, M. & POST, S.R. (2001). P2Y receptors of MDCK cells: epithelial cell regulation by extracellular nucleotides. Clin. Exp. Pharmacol. Physiol., 28, 351-354.
28. 2-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis. J. Biol. Chem., 274, 28900-28908.
29. 2-adrenergic receptor. J. Biol. Chem., 273, 322-328.
30. LIU, H.S., JAN, M.S., CHOU, C.K., CHEN, P.H. & KE, N.J. (1999). Is green fluorescent protein toxic to the living cells? Biochem. Biophys. Res. Commun., 260, 712-717.
31. LIU, R., GUTIERREZ, A.M., RING, A. & PERSSON, A.E. (2002). Nitric oxide induces resensitization of P2Y nucleotide receptors in cultured rat mesangial cells. J. Am. Soc. Nephrol., 13, 313-321.
32. LUIS ALBASANZ, J., FERNANDEZ, M. & MARTIN, M. (2002). Internalization of metabotropic glutamate receptor in C6 cells through clathrin-coated vesicles. Brain Res. Mol. Brain Res., 99, 54-66.
33. LUSTIG, K.D., SHIAU, A.K., BRAKE, A.J. & JULIUS, D. (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A., 90, 5113-5117.
34. MÜLLER, C.E. (2002). P2-pyrimidinergic receptors and their ligands. Curr. Pharm. Des., 8, 2353-2369.
35. 1 receptor agonists. J. Med. Chem., 45, 5384-5396.
36. 12 receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides. Mol. Pharmacol., 60, 416-420.
37. OSTROM, R.S., GREGORIAN, C. & INSEL, P.A. (2000). Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J. Biol. Chem., 275, 11735-11739.
38. RALEVIC, V. & BURNSTOCK, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
39. RICE, W.R., BURTON, F.M. & FIEDELDEY, D.T. (1995). Cloning and expression of the alveolar type II cell P2u-purinergic receptor. Am. J. Respir. Cell Mol. Biol., 12, 27-32.
40. RYBIN, V.O., XU, X., LISANTI, M.P. & STEINBERG, S.F. (2000). Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J. Biol. Chem., 275, 41447-41457.
41. 1 receptor to caveolae-related rafts. Mol. Pharmacol., 61, 546-553.
42. SAK, K., SAMUEL, K., KELVE, M. & WEBB, T.E. (2001). Pharmacological characterisation of pyrimidinoceptor responses in NG108-15 cells. Eur. J. Pharmacol., 415, 127-133.
43. SCHÄFER, R., SEDEHIZADE, F., WELTE, T. & REISER, G. (2003). ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 285, L376-L385.
44. 2 receptor. Mol. Pharmacol., 54, 485-494.
45. 2+. Br. J. Pharmacol., 139, 1014-1022.
46. TOLBERT, L.M. & LAMEH, J. (1996). Human muscarinic cholinergic receptor Hm1 internalizes via clathrin-coated vesicles. J. Biol. Chem., 271, 17335-17342.
47. i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience, 86, 597-609.
48. VAN DAM, E.M. & STOORVOGEL, W. (2002). Dynamin-dependent transfertin receptor recycling by endosome-derived clathrin-coated vesicles. Mol. Biol. Cell, 13, 169-182.
49. VAN DAM, E.M., TEN BROEKE, T., JANSEN, K., SPIJKERS, P. & STOORVOGEL, W. (2002). Endocytosed transferrin receptors recycle via distinct dynamin and phosphatidylinositol 3-kinase-dependent pathways. J. Biol. Chem., 277, 48876-48883.
50. 11 receptor in stably transfected haematological cell lines. Mol. Cell. Biochem., 213, 75-81.
51. 1 receptor tagged with green-fluorescent protein: high-affinity ligand recognition of adenosine diphosphates and triphosphates and selectivity identical to that of the wild-type receptor. Biochem. Pharmacol., 59, 791-800.
52. VON KÜGELGEN, I. & WETTER, A. (2000). Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedebergs Arch. Pharmacol., 362, 310-323.
53. WANG, Y., PENNOCK, S., CHEN, X. & WANG, Z. (2002). Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol. Cell. Biol., 22, 7279-7290.
54. WEBB, T.E., SIMON, J., KRISHEK, B.J., BATESON, A.N., SMART, T.G., KING, B.F., BURNSTOCK, G. & BARNARD, E.A. (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett., 324, 219-225.
55. XING, M., FIRESTEIN, B.L., SHEN, G.H. & INSEL, P.A. (1997). Dual role of protein kinase C in the regulation of cPLA2-mediated arachidonic acid release by P2U receptors in MDCK-D1 cells: involvement of MAP kinase-dependent and -independent pathways. J. Clin. Invest., 99, 805-814.
56. 2 receptor of MDCK cells: cloning, expression, and cell-specific signaling. Am. J. Physiol. Renal Physiol., 279, F1045-F1052.